title: Complete rescue of cerebrovascular function in aged Alzheimer's disease transgenic mice by antioxidants and pioglitazone, a peroxisome proliferator-activated receptor gamma agonist.
abstract: Accumulating evidence suggests that cerebrovascular dysfunction is an important factor in the pathogenesis of Alzheimer's disease (AD). Using aged ( approximately 16 months) amyloid precursor protein (APP) transgenic mice that exhibit increased production of the amyloid-beta (Abeta) peptide and severe cerebrovascular and memory deficits, we examined the capacity of in vivo treatments with the antioxidants N-acetyl-L-cysteine (NAC) and tempol, or the peroxisome proliferator-activated receptor gamma agonist pioglitazone to rescue cerebrovascular function and selected markers of AD neuropathology. Additionally, we tested the ability of pioglitazone to normalize the impaired increases in cerebral blood flow (CBF) and glucose uptake (CGU) induced by whisker stimulation, and to reverse spatial memory deficits in the Morris water maze. All compounds fully restored cerebrovascular reactivity of isolated cerebral arteries concomitantly with changes in proteins regulating oxidative stress, without reducing brain Abeta levels or Abeta plaque load. Pioglitazone, but not NAC, significantly attenuated astroglial activation and improved, albeit nonsignificantly, the reduced cortical cholinergic innervation. Furthermore, pioglitazone completely normalized the CBF and CGU responses to increased neuronal activity, but it failed to improve spatial memory. Our results are the first to demonstrate that late pharmacological intervention with pioglitazone not only overcomes cerebrovascular dysfunction and altered neurometabolic coupling in aged APP mice, but also counteracts cerebral oxidative stress, glial activation, and, partly, cholinergic denervation. Although early or combined therapy may be warranted to improve cognition, these findings unequivocally point to pioglitazone as a most promising strategy for restoring cerebrovascular function and counteracting several AD markers detrimental to neuronal function.
authors.affiliation: Laboratory of Cerebrovascular Research, Montréal Neurological Institute, McGill University, Montréal, Québec, Canada.
authors.forename: Nektaria
authors.initials: N
authors.lastname: Nicolakakis
authors.forename: Tahar
authors.initials: T
authors.lastname: Aboulkassim
authors.forename: Brice
authors.initials: B
authors.lastname: Ongali
authors.forename: Clotilde
authors.initials: C
authors.lastname: Lecrux
authors.forename: Priscilla
authors.initials: P
authors.lastname: Fernandes
authors.forename: Pedro
authors.initials: P
authors.lastname: Rosa-Neto
authors.forename: Xin-Kang
authors.initials: XK
authors.lastname: Tong
authors.forename: Edith
authors.initials: E
authors.lastname: Hamel
mesh_terms: D000109:Acetylcholine / Q000378:metabolism; D000111:Acetylcysteine / Q000627:therapeutic use*; D000375:Aging; D000544:Alzheimer Disease / Q000150:complications / Q000235:genetics; D016229:Amyloid beta-Peptides / Q000378:metabolism; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000627:therapeutic use*; D001522:Behavior, Animal / Q000187:drug effects; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000209:etiology / Q000235:genetics; D004195:Disease Models, Animal; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D008568:Memory / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009154:Mutation / Q000235:genetics; D009419:Nerve Tissue Proteins / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D047495:PPAR gamma / Q000819:agonists; D010446:Peptide Fragments / Q000378:metabolism; D000077205:Pioglitazone; D013482:Superoxide Dismutase / Q000378:metabolism; D045162:Thiazolidinediones / Q000627:therapeutic use*; D000099156:Superoxide Dismutase 2
chemical_list: D000109:Acetylcholine; D000111:Acetylcysteine; D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D000975:Antioxidants; D007004:Hypoglycemic Agents; D009419:Nerve Tissue Proteins; D019001:Nitric Oxide Synthase; D047495:PPAR gamma; D010446:Peptide Fragments; D000077205:Pioglitazone; D013482:Superoxide Dismutase; D045162:Thiazolidinediones; D000099156:Superoxide Dismutase 2; C075222:amyloid beta-protein (1-42)
references.citation: J Neurochem. 2007 Aug;102(4):1220-31
references.pmid: 17472705
references.citation: Ann Neurol. 2005 Jun;57(6):789-94
references.pmid: 15929050
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18727-32
references.pmid: 17121991
references.citation: Microcirculation. 2006 Oct-Nov;13(7):567-75
references.pmid: 16990215
references.citation: J Neurosci. 2005 Feb 16;25(7):1769-77
references.pmid: 15716413
references.citation: J Alzheimers Dis. 2006 Sep;10(1):89-109
references.pmid: 16988486
references.citation: Neuroscience. 2001;104(4):947-55
references.pmid: 11457582
references.citation: Am J Geriatr Psychiatry. 2005 Nov;13(11):950-8
references.pmid: 16286438
references.citation: Behav Brain Res. 2007 Jan 25;176(2):230-6
references.pmid: 17116337
references.citation: Nat Neurosci. 1999 Feb;2(2):157-61
references.pmid: 10195200
references.citation: J Neurosci. 2000 Jun 1;20(11):4050-8
references.pmid: 10818140
references.citation: Prog Brain Res. 2004;145:171-8
references.pmid: 14650915
references.citation: N Engl J Med. 2005 Jun 9;352(23):2379-88
references.pmid: 15829527
references.citation: J Cereb Blood Flow Metab. 2001 Mar;21(3):253-61
references.pmid: 11295880
references.citation: Hypertension. 1999 Jan;33(1 Pt 2):424-8
references.pmid: 9931141
references.citation: N Engl J Med. 2004 Jul 1;351(1):56-67
references.pmid: 15229308
references.citation: Pharmacogenomics J. 2006 Jul-Aug;6(4):246-54
references.pmid: 16446752
references.citation: J Appl Physiol (1985). 2006 Jan;100(1):318-27
references.pmid: 16357085
references.citation: Exp Neurol. 2006 Jun;199(2):265-73
references.pmid: 16515786
references.citation: J Cereb Blood Flow Metab. 2001 Mar;21(3):244-52
references.pmid: 11295879
references.citation: Trends Neurosci. 2005 Apr;28(4):202-8
references.pmid: 15808355
references.citation: Neurology. 2001 Oct 23;57(8):1515-7
references.pmid: 11673605
references.citation: Neurotoxicology. 2008 Mar;29(2):318-27
references.pmid: 18294692
references.citation: J Appl Physiol (1985). 2006 Mar;100(3):1059-64
references.pmid: 16467392
references.citation: J Neurosci Methods. 1984 May;11(1):47-60
references.pmid: 6471907
references.citation: Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8526-31
references.pmid: 12815103
references.citation: Aging Cell. 2007 Jun;6(3):361-70
references.pmid: 17517043
references.citation: Circulation. 2002 May 14;105(19):2296-302
references.pmid: 12010913
references.citation: Vascul Pharmacol. 2007 Jun;46(6):456-62
references.pmid: 17337254
references.citation: Kidney Int. 2001 May;59(5):1859-64
references.pmid: 11318957
references.citation: Brain Res. 1992 Jun 12;582(2):186-95
references.pmid: 1327402
references.citation: Neuroscience. 2006 Feb;137(3):937-48
references.pmid: 16325343
references.citation: Am J Physiol. 1993 Aug;265(2 Pt 2):H581-5
references.pmid: 8368361
references.citation: J Neurosci. 2003 Sep 17;23(24):8453-9
references.pmid: 13679413
references.citation: Neuroscience. 1999;92(1):163-75
references.pmid: 10392839
references.citation: Metabolism. 2001 Jan;50(1):3-11
references.pmid: 11172467
references.citation: J Neurosci. 2006 May 17;26(20):5340-6
references.pmid: 16707786
references.citation: J Neurosci. 2005 Nov 30;25(48):11165-74
references.pmid: 16319316
references.citation: Brain. 2005 Jun;128(Pt 6):1442-53
references.pmid: 15817521
references.citation: Nat Clin Pract Neurol. 2007 Sep;3(9):496-504
references.pmid: 17805244
references.citation: J Hypertens. 2001 Jul;19(7):1233-44
references.pmid: 11446713
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jul;283(1):H315-23
references.pmid: 12063304
references.citation: Nature. 2006 Mar 16;440(7082):352-7
references.pmid: 16541076
references.citation: J Appl Physiol (1985). 2006 Jan;100(1):328-35
references.pmid: 16357086
references.citation: Physiol Rev. 2006 Jul;86(3):1009-31
references.pmid: 16816144
references.citation: Life Sci. 2006 Nov 2;79(23):2209-16
references.pmid: 16904700
references.citation: Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1347-52
references.pmid: 18202172
references.citation: Am J Physiol Heart Circ Physiol. 2004 Feb;286(2):H742-8
references.pmid: 14551045
references.citation: JAMA. 2001 Nov 7;286(17):2120-7
references.pmid: 11694153
references.citation: Exp Physiol. 2008 Jan;93(1):116-20
references.pmid: 17911359
references.citation: Neuroimage. 2006 Jan 1;29(1):99-105
references.pmid: 16084741
references.citation: J Neurochem. 2003 Mar;84(5):1173-83
references.pmid: 12603840
references.citation: Nat Med. 2003 Apr;9(4):453-7
references.pmid: 12612547
references.citation: Nat Neurosci. 2003 Jan;6(1):43-50
references.pmid: 12469126
references.citation: Neuroscience. 2005;132(1):73-86
references.pmid: 15780468
references.citation: Science. 1988 Nov 11;242(4880):941-4
references.pmid: 3263703
references.citation: Lancet Neurol. 2004 Mar;3(3):184-90
references.pmid: 14980533
references.citation: Prog Neurobiol. 2002 Oct;68(3):209-45
references.pmid: 12450488
references.citation: Neurology. 2004 Dec 28;63(12):2332-40
references.pmid: 15623696
references.citation: Nat Biotechnol. 2000 Jun;18(6):655-60
references.pmid: 10835605
references.citation: Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9572-7
references.pmid: 12881482
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9735-40
references.pmid: 10944232
references.citation: J Neurosci. 2003 Aug 20;23(20):7504-9
references.pmid: 12930788
references.citation: J Cardiovasc Pharmacol. 2005 Dec;46(6):773-8
references.pmid: 16306801
references.citation: Neurobiol Aging. 2000 Mar-Apr;21(2):321-30
references.pmid: 10867217